Fn14-targeted BiTE and CAR-T cells demonstrate potent preclinical activity against glioblastoma
Gaowei Li(Sichuan University), Liangxue Zhou(University of Electronic Science and Technology of China), Kunhong Zhong(Sichuan University), Yuelong Wang(Huaqiao University), Aiping Tong(Chengdu Medical College), Yi Cao(Sichuan University), Guoqing Wang(Universiti Sains Malaysia), Chang Liu(Sichuan University), Linjun Cai(Sichuan University), Zongliang Zhang(Sichuan University), Lingyu Yu(Sichuan University), Jianhan Huang(Shanghai Medical College of Fudan University), Xin Tang(Sichuan University)
Cited by 32
Related Papers
A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity
|Nature|2020|849
A Review of Graph Neural Networks and Their Applications in Power Systems
|Journal of Modern Power Systems and Clean Energy|2022|387
B7-H3 as a Novel CAR-T Therapeutic Target for Glioblastoma
|Molecular Therapy — Oncolytics|2019|215
Long-term results of operation for 420 patients with early squamous cell esophageal carcinoma discovered by screening
|The Annals of Thoracic Surgery|2004|197